» Articles » PMID: 30854216

A Novel Germline Mutation of the Gene in Familial Interstitial Pneumonia

Overview
Journal Hum Genome Var
Date 2019 Mar 12
PMID 30854216
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Different genes related to alveolar stability have been associated with familial interstitial pneumonia (FIP). Here, we report a novel, rare variant in a family with idiopathic interstitial pneumonia (IIP). We performed whole-exome sequencing on germline DNA samples from four members of one family; three of them showed signs of pulmonary fibrosis (idiopathic interstitial pneumonia) with autosomal-dominant inheritance. A heterozygous single nucleotide variant c.532 G > A in the gene has been identified. This variant encodes the substitution p.(Val178Met), localized within the carbohydrate recognition domain of surfactant protein A and segregates with the genes causing idiopathic interstitial pneumonia. This rare variant has not been previously reported. We also analyzed the detected sequence variant in the protein structure . The replacement of valine by the larger methionine inside the protein may cause a disruption in the protein structure. The c.532 G > A variant was further validated using Sanger sequencing of the amplicons, confirming the diagnosis in all symptomatic family members. Moreover, this variant was also found by Sanger sequencing in one other symptomatic family member and one young asymptomatic family member. The autosomal-dominant inheritance, the family history of IIP, and the evidence of a mutation occurring in part of the gene all suggest a novel variant that causes FIP.

Citing Articles

Genetic Risk Factors in Idiopathic and Non-Idiopathic Interstitial Lung Disease: Similarities and Differences.

Cerri S, Manzini E, Nori O, Pacchetti L, Rossi L, Turchiano M Medicina (Kaunas). 2025; 60(12.

PMID: 39768847 PMC: 11677115. DOI: 10.3390/medicina60121967.


Unraveling the enigma: The emerging significance of pulmonary surfactant proteins in predicting, diagnosing, and managing COVID-19.

Bastani M, Jalilian S Immun Inflamm Dis. 2024; 12(6):e1302.

PMID: 38860749 PMC: 11165688. DOI: 10.1002/iid3.1302.


Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.

Luyapan J, Bosse Y, Li Z, Xiao X, Rosenberger A, Hung R Hum Mol Genet. 2023; 32(18):2842-2855.

PMID: 37471639 PMC: 10481107. DOI: 10.1093/hmg/ddad095.


Rare surfactant-related variants in familial and sporadic pulmonary fibrosis.

Sutton R, Trejo Bittar H, Sullivan D, Silva A, Bahudhanapati H, Parikh A Hum Mutat. 2022; 43(12):2091-2101.

PMID: 36135709 PMC: 9771972. DOI: 10.1002/humu.24476.


Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis.

Abbasi A, Chen C, Gandhi C, Wu R, Pardo A, Selman M Front Immunol. 2022; 13:842745.

PMID: 35720392 PMC: 9201215. DOI: 10.3389/fimmu.2022.842745.


References
1.
Talbert J, Schwartz D, Steele M . Familial Interstitial Pneumonia (FIP). Clin Pulm Med. 2014; 21(3):120-127. PMC: 4263205. DOI: 10.1097/cpm.0000000000000034. View

2.
Spagnolo P, Luppi F, Cerri S, Richeldi L . Genetic testing in diffuse parenchymal lung disease. Orphanet J Rare Dis. 2012; 7:79. PMC: 3489730. DOI: 10.1186/1750-1172-7-79. View

3.
Steele M, Speer M, Loyd J, Brown K, Herron A, Slifer S . Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med. 2005; 172(9):1146-52. PMC: 2718398. DOI: 10.1164/rccm.200408-1104OC. View

4.
Lee H, Ryu J, Wittmer M, Hartman T, Lymp J, Tazelaar H . Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest. 2005; 127(6):2034-41. DOI: 10.1378/chest.127.6.2034. View

5.
Tsakiri K, Cronkhite J, Kuan P, Xing C, Raghu G, Weissler J . Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A. 2007; 104(18):7552-7. PMC: 1855917. DOI: 10.1073/pnas.0701009104. View